{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023628","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.767067+00:00","generated_at":"2026-05-17T12:57:54.870889+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lixte Biotechnology updates treasury policy to allocate up to 25% to Bitcoin and other digital assets","bullets":["Board approved allocating up to 25% of corporate treasury to cryptocurrencies including Bitcoin.","Company will hold crypto assets with a fully regulated and compliant custodian.","CEO Geordan Pursglove cites long-term potential to hedge treasury and deliver shareholder returns.","Timing and size of purchases will depend on market conditions; policy retains flexibility.","Lixte is a clinical-stage biotech; treasury policy shift is a strategic capital allocation initiative."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023628","json":"https://secwatch.observer/filing/0001641172-25-023628.json","markdown":"https://secwatch.observer/filing/0001641172-25-023628.md","text":"https://secwatch.observer/filing/0001641172-25-023628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225023628/0001641172-25-023628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225023628/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:57:54.870889+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}